Reimbursement Pathways for Companion Diagnostics in Japan: SaMD, ctDNA, & Digital Biomarkers
- Demonstrating how laboratory testing services (including ctDNA, CGP, and digital biomarkers) are introduced as Software as a Medical Device (SaMD) in Japan
- Identifying critical reimbursement barriers limiting CDx implementation, including misalignment in current frameworks